Pages that link to "Q37736902"
Jump to navigation
Jump to search
The following pages link to The evolving role of adjuvant therapy in endometrial cancer (Q37736902):
Displaying 8 items.
- Effect of mTOR inhibitors in nude mice with endometrial carcinoma and variable PTEN expression status (Q34306540) (← links)
- Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit? (Q37590689) (← links)
- Antiangiogenic agents in advanced, persistent or recurrent endometrial cancer: a novel treatment option (Q38114478) (← links)
- Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study). (Q44391283) (← links)
- External-beam radiotherapy and/or HDR brachytherapy in postoperative endometrial cancer patients: clinical outcomes and toxicity rates. (Q45732678) (← links)
- Does the apex optimization line matter for single-channel vaginal cylinder brachytherapy planning? (Q55651535) (← links)
- Does postoperative radiotherapy provide any survival advantage over observation in stage IC endometrial cancer after comprehensive surgical staging? (Q85237507) (← links)
- Efficacy and Toxicity of Adjuvant Therapies for High-Risk Endometrial Cancer in Stage I-III: A Systematic Review and Network Meta-Analysis (Q99576082) (← links)